Newsdeck

Newsdeck

France expects AstraZeneca COVID-19 vaccine to be shared pro rata

The Covid-19 contagion has brought about a global gut-punch realisation: that health systems in even the wealthiest countries need shoring up, says the writer. (Photo: aa.com.tr / Wikipedia)

PARIS, June 15 (Reuters) - A deal between AstraZeneca and France over potential COVID-19 vaccines involves doses being split between countries on a pro-rata basis based on population, a source at the French President's office said on Monday.

The British drugmaker signed a contract with European governments at the weekend to supply the region with up to 400 million doses of its potential vaccine.

It was the first contract signed by Europe’s Inclusive Vaccines Alliance (IVA), a group formed by France, Germany, Italy and the Netherlands to secure vaccine doses for all member states as soon as possible.

“The principle of the deal is that the vaccines will be distributed pro rata, based on population,” the source at the French president’s office said. “What we’ve asked for and what has been agreed is for production to take place in Europe.”

France hopes to strike similar deals with other pharmaceuticals companies soon, the source added.

The vaccines – still in clinical trials – would be for all EU member states.

Governments have been scrambling to secure advance purchases of promising coronavirus immunisation treatments amid concerns within the EU that the bloc has not moved fast enough compared with other regions or countries.

In France, Sanofi’s call in May for a more collaborative European effort in the hunt for a vaccine sparked a backlash, especially after the French drugmaker’s CEO said doses produced in the United States, which had rapidly rolled out funding for research, would go to U.S. patients first.

Sanofi Chief Executive Paul Hudson later tempered his comments, emphasising that any coronavirus vaccine would reach all parts of the world.

Macron is due to visit a Sanofi Pasteur vaccine plant in France on Tuesday and will announce commitments on treatments and manufacturing capacities alongside the company, the source at the President’s office said.

(Reporting by Michel Rose and Matthias Blamont Writing by Sarah White Editing by David Goodman)

Gallery

Please peer review 3 community comments before your comment can be posted

A South African Hero: You

There’s a 99.7% chance that this isn’t for you. Only 0.3% of our readers have responded to this call for action.

Those 0.3% of our readers are our hidden heroes, who are fuelling our work and impacting the lives of every South African in doing so. They’re the people who contribute to keep Daily Maverick free for all, including you.

The equation is quite simple: the more members we have, the more reporting and investigations we can do, and the greater the impact on the country.

Be part of that 0.3%. Be a Maverick. Be a Maverick Insider.

Support Daily Maverick→
Payment options

MavericKids vol 3

How can a child learn to read if they don't have a book?

81% of South African children aged 10 can't read for meaning. You can help by pre-ordering a copy of MavericKids.

For every copy sold we will donate a copy to Gift of The Givers for children in need of reading support.